During the first 5 years (1981)(1982)(1983)(1984)(1985) of the liver transplantation program in Pittsburgh. a total (preoperative. intraoperative. and postoperative) of 18.668 packed red cell units. 23.627 fresh-frozen plasma units. 20.590 platelet units. and 4241 cryoprecipitate units was transfused for the procedures. This represents 3 to 9 percent of the total of blood products supplied by the Central Blood Bank to its 32 member hospitals. Six hundred thirty-six (636) transplants were performed on 485 patients in two hospitals: the Presbyterian University Hospital (564 beds) and Children's Hospital of Pittsburgh (236 beds). All of the blood components used in the operations were procured and released by the Central Blood Bank. This report describes some of these findings. TRANSFUSION 1987;27:222-225. THE DEVELOPMENT of liver transplantation (LTx) programs in recent years has put new demands on blood banks and transfusion services, which must devise means of coping with this new challenge. The Central Blood Bank of Pittsburgh (CBB) provides blood product support for 32 member hospitals. Two of these hospitals, Presbyterian University Hospital (PUH, 564 beds) and Children's Hospital of Pittsburgh (CHP, 236 beds) began doing liver transplants in 1981. The results of this experiment are reported here.
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Study Results
Figure I divides the numbers of operations done in Pittsburgh by I) the year of transplantation, 2) the hospital, and 3) the number of transplantations per patient. The numbers increased almost exponentially. Table I shows that, during the first 5 years, 290 adults and 195 children underwent 626 L Tx. Of these, 61 adults and 54 children received two livers, and 15 adults and II children received three livers. Table 2 shows the components used preoperatively, intraoperatively, and postoperatively. Most packed red cells (RBCs) (64%) and cryoprecipitate (86%) were used intraoperatively. Slightly more than one-half of the fresh-frozen plasma (FFP) and less than one-half of the platelets were From the Central Blood Bank of Pittsburgh and the Departments of Medicine and Surgery. University of Pittsburgh School of Medicine. Pittsburgh. Pennsylvania.
Received for publication June II. 1986; revision received August 2. 1986. and accepted August 12. 1986. 222 used in the operating room. Table 2 also compares the total number of components used for LTx with those distributed by CBB in the 5 years. The percentages ranged from 3 for RBC to 9.2 for FFP. Table 3 shows the use of blood components in the two hospitals in 1985, the last year of this study. These high percentages of blood component use are even more striking if the total of 31,000 patient admissions to the two hospitals is considered. The patients who had L Tx accounted for less than 0.01 percent of admissions, yet used approximately 25 percent of the blood. Figure 2 shows the mean use of blood components in the operating room per patient per year. After 1982, there were sharp drops in the use of RBC and FFP in adults. The use of platelets and cryoprecipitate followed no pattern, and the Table 2 . Total amounts of blood products (1981) (1982) (1983) (1984) (1985) for adults and children pediatric operations showed no trend to less use of blood components. Table 4 shows the decrease in blood use associated with second and third L Tx procedures in adults. Blood component use in the first L Tx was somewhat higher than that shown for all L Tx. Figure 3 shows that, if the interval between first and second L Tx in adults was 7 days or less, the blood use per patient was roughly one-half (RBC, 8 units; FFP, 10 units) that of the total for all second L Tx. Negligible differences were noted in repeat procedures among children who had L Tx. Table 5 shows the mean use of "blood" (RBC plus FFP) in 229 patients who fell into four of the major diagnostic categories: postnecrotic cirrhosis (PNq, primary biliary cirrhosis (PBq, sclerosing cholangitis (sq, and carcinoma/ neoplasia (CA). Because of the dependence on surgi- cal technique and the changes observed by year of surgery, the relationship between original diagnosis and blood use is difficult to express. It is obvious that in 1985 the PNC group that showed the greatest number of coagulation abnormalities also used the greatest amount of blood, whereas the CA group that showed the most normal coagulation patterns used the least blood.
Discussion The preceding findings demonstrate the major demands on blood banks in centers where significant numbers of L Tx are performed. Early studies from this laboratoryl.2 and the data shown in Table 5 sug_· gcst that blood use was at least to some extent dependent on the basic disease and the severity of preoperative coagulation defects. Improvements in surgical and anesthcsiologic techniques, intraoperative coagulation monitoring, and therapy of intraoperative fibrinolysis l may have contributed to the substantial drop in blood use per adult patient over the period described. Future developments may result in further decreases in blood component usage. DuC'to the surgical demands for blood and blood compo--nents (liver transplantation, heart and heart-lung. transplantation, etc.), eBB found it necessary to import from other blood banks about 2S percent.of the blood components used. Autologous intraopcra"': tive recovery of blood supplied only a moderate por- 2 I per min 4 was life-saving for some patients who were near exsanguination.
Another concern was the possible introduction of infectious or viral agents due to the large numbers of donor exposures. In 1982, the mean number of exposures per patient was 173 units of blood components; in 1983, it was 201. In these years, all blood was tested for hepatitis B surface antigen but not for antibodies to human immune deficiency virus (HIV) or for non-A, non-B (NAN B) hepatitis. If transmission of N ANB hepatitis can occur from 5 percentS of donor units and HIV from 0.04 percent,6 one would expect these transfusion-transmitted infections to be relatively common. Such was not observed, perhaps because new hepatitis was masked by the recurrence of old hepatitis. Drug-induced (cyclosporine) toxic effects on the new livers might also have obscured N ANB effects. High-dose immunosuppressive therapy mimicked the symptoms of acquired immune deficiency syndrome (AIDS), and the two may not be able to be differentiated. In fact, the Centers for Disease Control does not recognize a diagnosis of AIDS in clinically immunosuppressed patients with opportunistic infections. CBB is currently recom- mending that modified whole blood (platelet-poor 7 ) be su\)stituted for the first to units of both RBC and FFP, for a significant decrease in infection exposure.
In the early phases of the operation, platelets would not be added because of their possible thrombogenic effects. Coagulation factors in the reconstituted stored whole blood would be expected to be somewhat lower than in FFP.
